-
FDA warns biologics company about illegally manufacturing stem cell products: 5 insights
The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk. - 11/16/18 -
4 things to know about CollPlant
CollPlant is a regenerative medicine company focused on 3D bioprinting tissues and organs and developing orthobiologics. - 11/15/18 -
SpinalCyte's CybroCell injections led to sustained improvement in clinical study: 5 notes
SpinalCyte reported positive 12-month endpoint MRI outcomes in a clinical study of its CybroCell injection for degenerative disc disease. - 11/15/18
-
Researchers use stem cells to create personalized implants with low risk of rejection: 3 things to know
Tel Aviv (Israel) University researchers generated functional spinal cord, cardiac, cortical and adipogenic tissue implants from personalized hydrogels, according to results detailed in Advanced Materials. - 11/14/18 -
3 things to know about Cellect Biotechnology
Cellect Biotechnology is a regenerative medicine company. - 11/13/18 -
Bio2 Technologies to begin enrolling patients in cervical interbody fusion device trial: 3 insights
Bio2 Technologies received FDA approval to begin enrolling patients in an investigational device exemption clinical study to evaluate Vitrium as a cervical interbody fusion device. - 11/13/18 -
3 things to know about Kuros Biosciences' CEO
Joost de Bruijn, PhD, is the CEO of Kuros Biosciences. - 11/12/18
-
3 things to know about Histogenics
Histogenics develops restorative cell therapies for orthopedic pain relief. - 11/9/18 -
Imagion Biosystems incorporates 'printer & ink' business model for medical imaging
Imagion Biosystems is commercializing a form of medical imaging that uses biosafe nanoparticles to detect cancer, according to Proactive Investors Australia. - 11/8/18 -
SpinalCyte receives additional patents: 3 takeaways
Regenerative medicine company SpinalCyte was issued new patents in Hong Kong and Europe. - 11/8/18 -
3 things to know about Lattice Biologics' CEO
Guy Cook is the CEO of Lattice Biologics. - 11/7/18
-
Cellect receives patent approval for Apograft technology: 3 notes
Cellect Biotechnology received several patent grants for its Apograft technology. - 11/6/18 -
OsteoRemedies unveils 1st FDA-cleared dual-antibiotic spacer & bone cement: 3 notes
OsteoRemedies launched the first FDA-cleared dual-antibiotic spacer system and bone cement offering with gentamicin and vancomycin. - 11/2/18 -
MTF Biologics & Academy Medical join forces to bring allografts to the VA: 4 notes
MTF Biologics and Academy Medical partnered to bring human allograft tissues to Veteran Affairs medical centers across the U.S. - 11/2/18 -
ORTHOReBIRTH USA & neurosurgeon partner to develop biologic solutions: 3 notes
ORTHOReBIRTH USA signed a letter of intent to develop new biologic products with Loubert Suddaby, MD. - 11/2/18 -
5 things to know about Tobra Medical’s Bone Basket
The Tobra Medical Bone Basket is designed to help surgeons maximize the collection of autologous bone during drilling for bone graft. - 11/1/18 -
Dr. Sunny Patel performs 1st MACI case at North Carolina hospital: 4 notes
Orthopedic surgeon Sunny Patel, MD, performed a new knee cartilage replacement procedure at Burlington, N.C.-based Alamance Regional Medical Center, the Times-News reports. - 10/31/18 -
Through StemExpress partnership, Biological Industries USA adds human mesenchymal cells to portfolio: 3 notes
Biological Industries USA and StemExpress partnered to distribute StemExpress' human bone marrow-derived mesenchymal stem cells. - 10/31/18 -
Burst Biologics' umbilical cord blood-derived product is a promising option for spinal fusion, study finds
Cytokines present in umbilical cord blood-derived products can stimulate cellular processes necessary for bone regeneration, according to a study in Regenerative Medicine. - 10/30/18 -
Orthobiologics market to reach $10.1B by 2025 — 6 key market players
The global orthobiologics market is projected to reach $10.1 billion by 2025, according to Market Insights Reports. - 10/29/18